
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, an... Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.39 | 3.74280230326 | 10.42 | 11.36 | 10.22 | 83736 | 10.78862804 | CS |
4 | -1.85 | -14.6129541864 | 12.66 | 13.82 | 10.22 | 127402 | 11.76915749 | CS |
12 | -6.35 | -37.0046620047 | 17.16 | 18.76 | 10.22 | 118073 | 13.51446008 | CS |
26 | -4.395 | -28.9049654719 | 15.205 | 21.79 | 10.22 | 127179 | 15.8870627 | CS |
52 | -1.54 | -12.4696356275 | 12.35 | 21.79 | 10.22 | 114888 | 15.57230133 | CS |
156 | 1.53 | 16.4870689655 | 9.28 | 24.38 | 5.12 | 87846 | 14.32785773 | CS |
260 | -15.69 | -59.2075471698 | 26.5 | 36.85 | 5.12 | 96195 | 15.36002199 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions